For the monthly exercise status, 14,770 stock acquisition rights were exercised in the target month, with an exercise ratio of 9.99%. Unexercised rights decreased to 41,395 rights (4,139,500 shares). Number of shares delivered in the target month: 1,477,000 shares. Unexercised stock acquisition rights at the end of the previous month were 56,165 rights (5,616,500 shares), and the exercise restriction ratio was 2.49%. The target month is September 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4586","jir_company_name":"MedRx Co., Ltd","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4586-20261001-01.pdf","jir_short_summary":"For the monthly exercise status, 14,770 stock acquisition rights were exercised in the target month, with an exercise ratio of 9.99%. Unexercised rights decreased to 41,395 rights (4,139,500 shares). Number of shares delivered in the target month: 1,477,000 shares. Unexercised stock acquisition rights at the end of the previous month were 56,165 rights (5,616,500 shares), and the exercise restriction ratio was 2.49%. The target month is September 2026.","jir_summary":"### Overview of Monthly Exercise Status of Stock Acquisition Rights\nThis report conveys the monthly exercise status for September 2026 of the 35th stock acquisition rights (with an exercise price adjustment clause) issued by third-party allotment. The number of shares delivered in the target month was 1,477,000 shares. During the month, 14,770 stock acquisition rights were exercised, representing 9.99% of the total issued. The number of unexercised stock acquisition rights at the end of the target month decreased to 41,395 rights (4,139,500 shares). Compliance with exercise restrictions was confirmed, with the exercise restriction ratio calculated at 2.49%.\n\n### Background and Points of Future Attention\nThis exercise reflects utilization of stock acquisition rights under specific conditions and may affect dilution and exercise-related risks. The decrease in unexercised rights compared to the end of the previous month may suggest increased exercise intent. There were no significant period-specific movements or market disturbances; additional information is expected to be provided in future monthly disclosures.","jir_financial_highlights":"Number of shares delivered in the target month: 1,477,000 shares\nNumber of stock acquisition rights exercised in the target month: 14,770 rights\nRatio of stock acquisition rights exercised in the target month: 9.99%\nUnexercised stock acquisition rights (end of previous month): 56,165 rights (5,616,500 shares) (Decrease compared to end of previous month)\nUnexercised stock acquisition rights (end of month): 41,395 rights (4,139,500 shares)\nExercise restriction status (Total shares delivered \/ Listed shares \/ Exercise ratio): 1,477,000 shares \/ 59,365,100 shares \/ 2.49%","jir_category":"","jir_hashtags":"#MedRx, #StockAcquisitionRights, #EquityMarketInfo","jir_key_figures":"Number of shares delivered in the target month: 1,477,000 shares\nNumber of stock acquisition rights exercised in the target month: 14,770 rights\nTotal issued: 147,820 rights (of which exercised: 14,770 rights)\nUnexercised stock acquisition rights: End of month 41,395 rights (4,139,500 shares)\nExercise restriction ratio: 2.49%","jir_meta_title":"MedRx Co., Ltd \u2014 Monthly Exercise Status of 35th Stock Acquisition Rights (Third-Party Allotment) | September 2026","jir_meta_description":"Disclosure of MedRx Co., Ltd's monthly exercise status for the 35th stock acquisition rights in September 2026: 1,477,000 shares delivered, 14,770 rights exercised (9.99% exercise rate), unexercised rights decreased to 41,395 rights, exercise restriction ratio 2.49%.","jir_og_title":"MedRx Co., Ltd \u2014 September Monthly Exercise Status of Stock Acquisition Rights","jir_og_description":"Detailed monthly exercise status for September of the 35th stock acquisition rights by MedRx Co., Ltd: 1,477,000 shares delivered, 14,770 rights exercised, unexercised rights reduced to 41,395 rights.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59495,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-125597","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n